If lack of data was an impediment to roll out action plans against antimicrobial resistance (AMR), now that excuse has been yanked off. The recent publication of The Lancet’s global burden of bacterial antimicrobial resistance — an elaborate and studied estimate validated by using counterfactual analysis for the first time — comes at a time when the world, weary with battling COVID-19, seems to have lost steam to mount a robust AMR policy. But the report makes it clear that no slacking can be allowed on this front any longer; it estimated that 4.95 million deaths were associated with bacterial AMR in 2019 alone. (Read More)
Related Articles:
Be the first to comment